|
1 Company |
|
3 Products |
|
3 Products |
|
2 Mechanisms of Action |
|
0 Trials |
|
15 News |
|
- | cisplatin / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: HIPEC-IAP: HIPEC Using High Intra-abdominal Pressure (clinicaltrials.gov) - Feb 23, 2018
P2, N=38, Completed, Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting --> Completed | Trial primary completion date: Jun 2017 --> Nov 2017 | Trial completion date: Jun 2017 --> Nov 2017
- Trial completion, Enrollment change: Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients (clinicaltrials.gov) - Feb 8, 2017
P=N/A, N=55, Completed, Sponsor: Edward Hospital
Recruiting --> Completed | Trial primary completion date: Jun 2017 --> Nov 2017 | Trial completion date: Jun 2017 --> Nov 2017 Enrolling by invitation --> Completed | N=150 --> 55
- New trial, Surgery: Thrombin Generation and Platelet Activation in CRS/HIPEC (clinicaltrials.gov) - Jan 30, 2017
P=N/A, N=27, Completed, Sponsor: Ziekenhuis Oost-Limburg
- cisplatin / Generic mfg.
New P2 trial: HIPEC-IAP: HIPEC Using High Intra-abdominal Pressure (clinicaltrials.gov) - Oct 30, 2016
P2, N=38, Recruiting, Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Trial completion, Trial primary completion date, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Oct 9, 2015
P=N/A, N=39, Completed, Sponsor: Ohio State University Comprehensive Cancer Center
Enrolling by invitation --> Completed | N=150 --> 55 Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2012
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
Trial completion, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - Aug 12, 2015
P1, N=12, Completed, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2012 Active, not recruiting --> Completed
- Trial primary completion date, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=48, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Completed Trial primary completion date: Sep 2014 --> Jul 2015
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
Enrollment change, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - Jun 6, 2015
P1, N=12, Active, not recruiting, Sponsor: Case Comprehensive Cancer Center
Trial primary completion date: Sep 2014 --> Jul 2015 N=20 --> 12
- Clinical: Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients (clinicaltrials.gov) - Feb 27, 2015
P=N/A, N=150, Enrolling by invitation, Sponsor: Edward Hospital
- Trial completion, HEOR: HOPE: Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (clinicaltrials.gov) - Jul 23, 2014
P=N/A, N=10, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
N=20 --> 12 Active, not recruiting --> Completed
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
Enrollment closed, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - May 27, 2014
P1, N=20, Active, not recruiting, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment closed, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - May 19, 2014
P=N/A, N=48, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Jan 8, 2013
P=N/A, N=48, Recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
New P1 trial, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - Jul 26, 2012
P1, N=20, Recruiting, Sponsor: Case Comprehensive Cancer Center
- Enrollment closed, HEOR: HOPE: Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (clinicaltrials.gov) - Nov 30, 2011
P=N/A, N=10, Active, not recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting